1. Home
  2. ESTA vs MESO Comparison

ESTA vs MESO Comparison

Compare ESTA & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESTA
  • MESO
  • Stock Information
  • Founded
  • ESTA 2004
  • MESO 2004
  • Country
  • ESTA Costa Rica
  • MESO Australia
  • Employees
  • ESTA N/A
  • MESO N/A
  • Industry
  • ESTA Industrial Specialties
  • MESO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ESTA Health Care
  • MESO Health Care
  • Exchange
  • ESTA Nasdaq
  • MESO Nasdaq
  • Market Cap
  • ESTA 1.3B
  • MESO 1.3B
  • IPO Year
  • ESTA 2018
  • MESO N/A
  • Fundamental
  • Price
  • ESTA $45.26
  • MESO $11.06
  • Analyst Decision
  • ESTA Buy
  • MESO Buy
  • Analyst Count
  • ESTA 6
  • MESO 4
  • Target Price
  • ESTA $55.00
  • MESO $18.00
  • AVG Volume (30 Days)
  • ESTA 407.1K
  • MESO 205.5K
  • Earning Date
  • ESTA 08-05-2025
  • MESO 08-28-2025
  • Dividend Yield
  • ESTA N/A
  • MESO N/A
  • EPS Growth
  • ESTA N/A
  • MESO N/A
  • EPS
  • ESTA N/A
  • MESO N/A
  • Revenue
  • ESTA $170,235,000.00
  • MESO $5,670,000.00
  • Revenue This Year
  • ESTA $27.10
  • MESO $178.09
  • Revenue Next Year
  • ESTA $24.55
  • MESO $305.06
  • P/E Ratio
  • ESTA N/A
  • MESO N/A
  • Revenue Growth
  • ESTA 9.27
  • MESO N/A
  • 52 Week Low
  • ESTA $26.56
  • MESO $5.78
  • 52 Week High
  • ESTA $52.41
  • MESO $22.00
  • Technical
  • Relative Strength Index (RSI)
  • ESTA 64.78
  • MESO 50.02
  • Support Level
  • ESTA $34.34
  • MESO $10.32
  • Resistance Level
  • ESTA $47.11
  • MESO $10.86
  • Average True Range (ATR)
  • ESTA 2.42
  • MESO 0.35
  • MACD
  • ESTA 0.41
  • MESO 0.00
  • Stochastic Oscillator
  • ESTA 85.47
  • MESO 45.04

About ESTA Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

About MESO Mesoblast Limited

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

Share on Social Networks: